TKO Group Director Invests Nearly 1 Million in Shares Highlighting Insider Confidence
TikTok and YouTube Face Regulatory Scrutiny Over Child Safety Standards from UK Watchdog
Microsofts GitHub was positioned to win the AI coding race Outages got in the way
Nvidias Blockbuster Quarter China Concession and the 200 Billion Edge Computing Opportunity
Obsession and The Mandalorian Grogu Deliver Blockbuster Box Office Results
HC Wainwright Lifts Eton Pharmaceuticals Price Target Reaffirms Positive Outlook on Growth Strategy
EGO Q1 2026 Earnings EPS Surges Past Estimates by 33 Amid Operational Gains
NACCO Industries NC Q1 2026 Earnings EPS of 117 Reported Amid Limited Disclosure
BWLP Q4 2025 Earnings EPS Beats Estimates Amid Mixed Market Conditions
KG Q3 2024 Earnings A Loss of 016 per Share as Stock Declines
Health In Tech Inc HIT Q1 2026 Earnings EPS Meets Estimates Stock Slips 26
Labcorp Holdings Inc LH Q1 2026 Earnings EPS Tops Estimates Amid Strong Operational Execution
Main Street Capital MAIN Faces Selling Pressure Key Levels to Watch After 272 Decline
Lithium Americas LAC Slips 17 Hovers Near Key Support as Lithium Headwinds Persist
CareCloud Preferred Stock CCLDO Holds Steady Near Key Support as Traders Assess Yield Appeal
Columbus Circle Capital Corp II Warrants CMIIW Remain Flat at 034 as Investors Await Catalyst
Covista Inc CVSA Slides Marginally Holding Above Key Support
RubioModi Meeting Signals USIndia Energy Cooperation Amid Iran Conflict
NOG Q1 2026 Earnings EPS Beats Estimates by 789 Stock Declines
OSI Systems OSIS Holds Steady Near 220 Amid Modest Pullback
Arcellx ACLX Q4 2025 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage
BYRN Q1 2026 Earnings EPS Misses Estimates Stock Advances on Strategic Progress
MIND Q1 2026 Earnings Significant EPS Miss Weighs on Investor Sentiment
ConAgra Brands CAG Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain
CLLS Q1 2026 Earnings Narrowed Loss Surprises Amid Clinical Focus
CISS Q3 2025 Earnings Loss per Share of 058 Shares Decline 55
GPCR Q1 2026 Earnings Narrower Loss Highlights ClinicalStage Progress